Cargando…
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
Infection of the CNS with the SARS-CoV-2 can occur via different routes and results in para- or post-infectious manifestations with a variety of neurological symptoms. In patients with neurodegenerative diseases, SARS-CoV-2 is often associated with a higher fatality rate, which is a relevant problem...
Autores principales: | Lingor, Paul, Demleitner, Antonia F., Wolff, Andreas W., Feneberg, Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013492/ https://www.ncbi.nlm.nih.gov/pubmed/35434769 http://dx.doi.org/10.1007/s00702-022-02500-w |
Ejemplares similares
-
Parkinson’s disease therapy: what lies ahead?
por: Wolff, Andreas, et al.
Publicado: (2023) -
International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020) -
Commentary: When we don't know what we don't know
por: Paone, Gaetano
Publicado: (2020) -
Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021) -
From CERN to Entrepreneurship: we don't know what we don't know
por: Zucchelli, Piero
Publicado: (2017)